Soluble glucagon derivative could improve treatment of hypoglycemia

Glucagon is typically unstable in acidic or basic aqueous solutions, inhibiting its use in medical devices such as pens or pumps. Researchers at Purdue have developed a method of stabilizing glucagon and improving its solubility in aqueous form, allowing for numerous applications with no biological activity in the derivative form and will only be active when the native drug is regenerated. Read more about this research being done by Dr. Elizabeth Topp, Department Head and Dane O. Kildsig Chair of Industrial and Physical Pharmacy. 

Mega Menu Visual Content